Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 396 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 3,438 shares (to pay taxes)
  3. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 610 shares (to pay taxes)
  4. 4 Planned sale Head of Development sold 108 shares at $221.49 ($23,921)
  5. 4 Open-market buy Director bought 455 shares at $222.54 ($101,256)
  6. 4 Shares withheld for taxes EVP, Human Resources gave up 634 shares (to pay taxes)
  7. 4 Planned sale Head of Development sold 419 shares at $239.45 ($100,330)
  8. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 761 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,431 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Accounting Officer gave up 245 shares (to pay taxes)
  11. 4 Shares withheld for taxes Head of Global Product Strat. gave up 445 shares (to pay taxes)
  12. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 938 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 655 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Human Resources gave up 498 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes Head of Global Product Strat. gave up 621 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes Chief Accounting Officer gave up 253 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 765 shares (to pay taxes)
  20. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 638 shares (to pay taxes)

Page 6 of 86 · 1,714 filings